These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2222491)

  • 21. Purification and characterization of human biliverdin reductase.
    Maines MD; Trakshel GM
    Arch Biochem Biophys; 1993 Jan; 300(1):320-6. PubMed ID: 8424666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting the electrostatic interactions and pH-dependent activity of a family 11 glycosidase.
    Joshi MD; Sidhu G; Nielsen JE; Brayer GD; Withers SG; McIntosh LP
    Biochemistry; 2001 Aug; 40(34):10115-39. PubMed ID: 11513590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipyrromethane cofactor assembly in porphobilinogen deaminase.
    McNeill LA; Shoolingin-Jordan PM
    Biochem Soc Trans; 1998 Aug; 26(3):S286. PubMed ID: 9766005
    [No Abstract]   [Full Text] [Related]  

  • 24. Porphobilinogen deaminase activity in malignant proliferative disorders of the lymphatic system and bone marrow.
    Zawirska B; Usnarska-Zubkiewicz L; Gamian E
    Patol Pol; 1993; 44(1):13-7. PubMed ID: 8488077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery that the assembly of the dipyrromethane cofactor of porphobilinogen deaminase holoenzyme proceeds initially by the reaction of preuroporphyrinogen with the apoenzyme.
    Shoolingin-Jordan PM; Warren MJ; Awan SJ
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):373-6. PubMed ID: 8687374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porphobilinogen deaminase in human erythrocytes: purification of two forms with apparent molecular weights of 40 kDa and 42 kDa.
    Lannfelt L; Wetterberg L; Lilius L; Thunell S; Jörnvall H; Pavlu B; Wielburski A; Gellerfors P
    Scand J Clin Lab Invest; 1989 Nov; 49(7):677-84. PubMed ID: 2609111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a dipyrromethane cofactor at the catalytic site of E. coli porphobilinogen deaminase.
    Jordan PM; Warren MJ
    FEBS Lett; 1987 Dec; 225(1-2):87-92. PubMed ID: 3079571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-essential activation of rat liver porphobilinogen-deaminase by folic acid.
    Noriega GO; Juknat AA; Batlle AM
    Z Naturforsch C J Biosci; 1992; 47(5-6):416-9. PubMed ID: 1418238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a novel mechanism for cofactor assembly by Escherichia coli porphobilinogen deaminase.
    Awan SJ; Siligardi G; Warren MJ; Shoolingin-Jordan PM
    Biochem Soc Trans; 1997 Feb; 25(1):79S. PubMed ID: 9056977
    [No Abstract]   [Full Text] [Related]  

  • 30. Dipyrromethane cofactor assembly of porphobilinogen deaminase: formation of apoenzyme and preparation of holoenzyme.
    Shoolingin-Jordan PM; Warren MJ; Awan SJ
    Methods Enzymol; 1997; 281():317-27. PubMed ID: 9250996
    [No Abstract]   [Full Text] [Related]  

  • 31. Structural evidence for the partially oxidized dipyrromethene and dipyrromethanone forms of the cofactor of porphobilinogen deaminase: structures of the Bacillus megaterium enzyme at near-atomic resolution.
    Azim N; Deery E; Warren MJ; Wolfenden BA; Erskine P; Cooper JB; Coker A; Wood SP; Akhtar M
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):744-51. PubMed ID: 24598743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Porphobilinogen deaminase (PBGD)].
    Kondo M
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():891-4. PubMed ID: 8753580
    [No Abstract]   [Full Text] [Related]  

  • 33. Subcellular location of the tetrapyrrole synthesis enzyme porphobilinogen deaminase in higher plants: an immunological investigation.
    Witty M; Jones RM; Robb MS; Jordan PM; Smith AG
    Planta; 1996; 199(4):557-64. PubMed ID: 8818294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse mammary carcinoma porphobilinogenase and hydroxymethylbilane synthetase.
    Navone NM; Polo CF; Frisardi AL; Batlle AM
    Comp Biochem Physiol B; 1991; 98(1):67-71. PubMed ID: 2060282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinoma.
    Fontanellas A; Avila MA
    J Hepatol; 2022 Oct; 77(4):912-914. PubMed ID: 35798130
    [No Abstract]   [Full Text] [Related]  

  • 36. Kinetic and molecular parameters of human hepatic porphobilinogen deaminase.
    Mazzetti MB; Tomio JM
    Biochem Int; 1990; 21(3):463-71. PubMed ID: 2222491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of porphobilinogen deaminase from Euglena gracilis and studies of its kinetics.
    Williams DC; Morgan GS; McDonald E; Battersby AR
    Biochem J; 1981 Jan; 193(1):301-10. PubMed ID: 6796041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics.
    Edixhoven-Bosdijk A; de Rooij FW; de Baar-Heesakkers E; Wilson JH
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):861-6. PubMed ID: 12699244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of porphobilinogen deaminase from rat liver.
    Mazzetti MB; Tomio JM
    Biochim Biophys Acta; 1988 Nov; 957(1):97-104. PubMed ID: 3179323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria.
    Brownlie PD; Lambert R; Louie GV; Jordan PM; Blundell TL; Warren MJ; Cooper JB; Wood SP
    Protein Sci; 1994 Oct; 3(10):1644-50. PubMed ID: 7849582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.